Rosemary J. Boyton

Best Publications

• Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure

  Unknown

  569
  Citations

• Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial

  Edward S Chambers;Claire S Byrne;Douglas J Morrison;Kevin G Murphy

  454
  Citations

• Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

  Leo Swadling;Mariana O. Diniz;Nathalie M. Schmidt;Oliver E. Amin

  393
  Citations

• Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.

  Charlotte Manisty;Ashley D Otter;Thomas A Treibel;Áine McKnight

  388
  Citations

• The immunology of long COVID

  Unknown

  356
  Citations

• Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.

  Catherine J. Reynolds;Corinna Pade;Joseph M. Gibbons;David K. Butler

  350
  Citations

• What policy makers need to know about COVID-19 protective immunity.

  Daniel M Altmann;Daniel C Douek;Rosemary J Boyton

  290
  Citations

• Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).

  Pascal F Durrenberger;Anna Ettorre;Fatemah Kamel;Louise V Webb

  282
  Citations

• SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.

  Daniel M. Altmann;Rosemary J. Boyton

  275
  Citations

• Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression

  John D M Campbell;Karen F. Buckland;Sarah J. McMillan;Jennifer Kearley

  261
  Citations

• Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2

  Ian McDonald;Sam M. Murray;Catherine J. Reynolds;Daniel M. Altmann

  247
  Citations

• COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

  Unknown

  230
  Citations

• Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease

  R. J. Boyton;D. M. Altmann

  227
  Citations

• Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection.

  Catherine J. Reynolds;Leo Swadling;Joseph M. Gibbons;Corinna Pade

  209
  Citations

• COVID-19 vaccination: The road ahead

  Unknown

  209
  Citations

• Immunity to SARS-CoV-2 variants of concern.

  Daniel M. Altmann;Rosemary J. Boyton;Rupert Beale;Rupert Beale

  202
  Citations

• Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: Implications for immunotherapy.

  David J. Pinato;Sam M Murray;Alejandro Forner;Takahiro Kaneko

  185
  Citations

• Pulmonary defences to acute respiratory infection.

  Rosemary J Boyton;Peter J Openshaw

  168
  Citations

• Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.

  Catherine J Reynolds;Joseph M Gibbons;Corinna Pade;Kai-Min Lin

  145
  Citations

• Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.

  Letícia Adrielle dos Santos;Pedro Germano de Góis Filho;Ana Maria Fantini Silva;João Victor Gomes Santos

  125
  Citations